Par Drugs And Chemicals Ltd. Hits Upper Circuit on NSE, 27 October 2026

Healthcare and pharmaceutical names can be compared on paper, but the Par Drugs And Chemicals upper circuit on 27 October 2026 is a single-stock event. Par Drugs And Chemicals Ltd. (PAR) moved from a previous close of Rs 104.28 to the band limit of Rs 109.49 on NSE, a 5% rise, and its market cap is Rs 128.31 crore.

The stock was locked at that ceiling when this was written, a position that keeps the counter in front of short-term market participants.

Key Takeaways

• Par Drugs And Chemicals Ltd. (PAR) hit the upper circuit on NSE at Rs 109.49 on 27 October 2026.
• The session move was +5% against a previous close of Rs 104.28.
• Market capitalisation stood at Rs 128.31 crore with a PE ratio of 8.85.
• No official company announcement or verified catalyst was confirmed at the time of writing.
• A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

All figures above are as of 27 October 2026, sourced from Univest market data for the NSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

Par Drugs And Chemicals Ltd. opened on NSE at Rs 107, above the previous close of Rs 104.28, then touched a day low of Rs 104.1 before moving up to Rs 109.49. That last level is both the day’s high and the band limit, so the stock spent part of the session below its previous close before the climb. The gain came to Rs 5.21, or 5%.

The numbers are all from NSE. Staying on one exchange keeps the open, the range and the reference close consistent with each other, as bands and previous-close values are not identical everywhere. Rs 109.49 was the limit the price reached during the session.

Why Par Drugs And Chemicals Ltd. Hit Upper Circuit

The upper circuit came after buying interest took Par Drugs And Chemicals Ltd. to the edge of its exchange-defined price band. When this was written, there was no confirmed company announcement and no verified external catalyst, which leaves price action and sentiment as the readable explanation.

Pharmaceutical sector news, earnings, corporate actions and market chatter are not cited as drivers, since none is confirmed. If a verified announcement turns up later, a separate update would carry it.

The Rs 109.49 band level was reached in the session.

What the Par Drugs And Chemicals Upper Circuit Means

The upper circuit is the ceiling an exchange sets on a stock’s price for one session. For Par Drugs And Chemicals Ltd., that ceiling was Rs 109.49 on 27 October 2026.

Ceilings of this kind exist to slow extreme moves and keep trading orderly. A glance at pharma peers can show whether the move was shared or isolated, but it cannot turn the session into a forecast, since the circuit is a feature of market structure and not a signal of future returns.

Par Drugs And Chemicals Ltd. Fundamentals and Valuation

On reported data, the PE ratio is 8.85 and the PB ratio is 1.1. Book value stands at Rs 94.84 per share, EPS at 11.78 and market cap at Rs 128.31 crore. None of this amounts to a buy, sell or hold view, and it is shown only to give the price move some context.

A PB ratio of 1.1 sits only slightly above book value per share, so the premium over reported net assets is narrow, although such gaps can reflect growth expectations, asset quality or limited trading depth in a smaller counter.

Against pharma peers, ratios like these can place the company in context, yet they describe the business and not the day’s price event. Valuation and return measures still need their own review alongside any sharp one-day move, because a single session says little about the underlying business.

Peer and Sector Context

Par Drugs And Chemicals Ltd. belongs to the Pharmaceuticals & Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.

Several of these peers are far larger by market capitalisation than Par Drugs And Chemicals Ltd. Size differences change liquidity and cost of capital, so the table is sector context rather than a like-for-like ranking.

Par Drugs And Chemicals Ltd.’s PE ratio was 8.85, compared with an available peer PE average of 41.19, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Technical Snapshot

The technical snapshot adds context: RSI was 86.13.

What Readers Should Know

Of everything above, one point is settled: on 27 October 2026 the NSE price of Par Drugs And Chemicals Ltd. went to the Rs 109.49 upper circuit, up 5% for the day.

A sector comparison helps place the session but leaves two things open. It cannot show that the price at the band was available to trade, as buyers queue while sellers step back, and it cannot supply a catalyst, which had not been confirmed when this was written.

As a market update, the event says little beyond strong near-term interest at the band. Business fundamentals, valuation, liquidity, risk and confirmed company disclosures remain separate matters.

Frequently Asked Questions

Why did Par Drugs And Chemicals Ltd. hit upper circuit on 27 October 2026?

The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

What was PAR share price on 27 October 2026?

The last traded price used in this article was Rs 109.49 on NSE. That price matched the upper circuit price captured for the event.

What was the upper circuit price for PAR?

The upper circuit price was Rs 109.49. The stated exchange upper circuit limit was Rs 109.49. The event numbers in this article are aligned to NSE.

What is Par Drugs And Chemicals Ltd.’s market cap and PE ratio?

Par Drugs And Chemicals Ltd.’s market cap was Rs 128.31 crore. PE ratio was 8.85.

Which exchange and data source were used?

The selected exchange was NSE. The article uses Univest market data available at the time of generation, captured on 27 October 2026.

Does hitting an upper circuit mean Par Drugs And Chemicals Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Par Drugs And Chemicals Ltd. shares when the stock is at the upper circuit?

It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.

What happens the next trading session after an upper circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the upper circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Par Drugs And Chemicals Ltd. the stated limit was Rs 109.49. For this session, Par Drugs And Chemicals Ltd. moved 5%.